Global In Vitro Diagnostics (IVD) Market 2022 - Snapshot

September 2022 | 46 pages | ID: GA05C1279741EN
Gen Consulting Company

Abstracts

The global in vitro diagnostics market is anticipated to increase by USD 38 billion till 2028 at an average annual growth of 6.1 percent as per the latest report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market data on in vitro diagnostics can be segmented by product: instruments, reagents, software & services. In vitro diagnostics market is further segmented by technology: clinical chemistry & immunochemistry, clinical microbiology, hematology, molecular diagnostics (MDx), POC testing, self-monitoring of blood glucose (SMBG), tissue diagnostics, others. Globally, the clinical chemistry & immunochemistry segment made up the largest share of the in vitro diagnostics market. Based on application, the in vitro diagnostics market is segmented into: autoimmune diseases, cardiac diseases, diabetes, infectious diseases, nephrological diseases, oncology, others. On the basis of end user, the in vitro diagnostics market also can be divided into: hospitals, laboratories, homecare, others. In vitro diagnostics market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

The global in vitro diagnostics market is highly competitive. As of 2021, the major players in the global in vitro diagnostics market were Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Illumina Inc., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Qiagen N.V., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Werfen S.A.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global In Vitro Diagnostics Market
• Identify segments/areas to invest in over the forecast period in the Global In Vitro Diagnostics Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. IN VITRO DIAGNOSTICS MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY PRODUCT

Instruments
Reagents
Software & services

PART 5. MARKET BREAKDOWN BY TECHNOLOGY

Clinical chemistry & immunochemistry
Clinical microbiology
Hematology
Molecular diagnostics (MDx)
POC testing
Self-monitoring of blood glucose (SMBG)
Tissue diagnostics
Others

PART 6. MARKET BREAKDOWN BY APPLICATION

Autoimmune diseases
Cardiac diseases
Diabetes
Infectious diseases
Nephrological diseases
Oncology
Others

PART 7. MARKET BREAKDOWN BY END USER

Hospitals
Laboratories
Homecare
Others

PART 8. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 9. KEY COMPANIES

Abbott Laboratories
Becton, Dickinson and Company
bioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
Hologic, Inc.
Illumina, Inc.
Ortho-Clinical Diagnostics, Inc.
PerkinElmer, Inc.
Qiagen N.V.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific, Inc.
Werfen, S.A.

PART 10. METHODOLOGY